Pharma Technology Solutions
Three proprietary tools that eliminate high-friction activities in pharma writing and PV operations.
Where teams lose time and credibility.
Blind Journal Selection
Teams pick journals on impact factor alone, with no view of acceptance rates, APC data or desk-rejection risk.
Indefensible PV Staffing
PV resource plans are built on intuition, not on FAERS-driven drug-risk tiering, and they fail at inspection.
Audit-Fragile Literature Reviews
Manual literature monitoring lacks validated search strings, evidence tables and audit trails.
How we close the gap.
Our three in-house tools are positioned by business outcome, not features. They are ICS-built systems, not licensed software, purpose-built for the highest-friction activities in pharma scientific writing and PV operations, making delivery faster, more accurate and inspection-ready.
See the frameworks behind thisScientific Writing Tool
AI-verified journal shortlists with acceptance rates, APC data and desk-rejection risk scoring. No more blind impact-factor-only journal selection.
For: Medical Affairs · R&D · Publication TeamsPV Resource Allocation Tool
FAERS-driven drug risk tiering and defensible staffing plans, inspection-ready and audit-traceable.
For: PV Departments · CROs · Drug Safety TeamsLiterature Monitoring Tool
ICH E2C(R2) and GVP Module VI compliant periodic literature reviews. Validated search strings, evidence tables and audit trails.
For: PV · Medical Affairs · RegulatoryWhat we deliver.
Scientific Writing Tool
AI-verified journal shortlists with acceptance rates, APC data and desk-rejection risk scoring.
Learn MorePV Resource Allocation Tool
FAERS-driven drug risk tiering and defensible, audit-traceable staffing plans.
Learn MoreLiterature Monitoring Tool
ICH E2C(R2) and GVP Module VI compliant periodic literature reviews with validated search strings.
Learn MoreThe technology behind this practice.
Our proprietary Pharos platform gives this practice an edge most vendors cannot match.
Built for your role.
How to engage.
- 1
Project-Based
Fixed scope, clear timeline, single deliverable. Best for one-off manuscripts, decks, or audits.
- 2
Retainer / FSP
Dedicated expert team on-call with scalable capacity. Best for Medical Affairs or PV departments with ongoing volume.
- 3
Co-sourcing
Shared responsibility alongside your in-house team. Best for capacity augmentation without full outsource.
Request the Pharma Technology Solutions Capability Deck
Our detailed documentation of services, frameworks and engagement models for this practice area.
Request Capability DeckTrusted by teams in regulated environments.
The literature monitoring used to be a black box at audit. Now every search is reproducible and every decision is traceable. Our last inspection was the calmest one we have had.
For the first time our PV staffing is something I can actually defend with data. Risk-tiered drugs, activity-level plans, no more arguing about headcount on gut feel.
We were losing months to desk rejections we could not explain. Ichelon rebuilt our pre-submission process around journal fit and embedded reporting standards, and our acceptance rate on first submission climbed noticeably within two cycles.
Read more from the team.
How to Choose a Journal Beyond Impact Factor
Impact factor is the worst single metric to select a journal on. Acceptance probability, scope fit and APC reality matter far more.
Read Pharma TechnologyWhy FAERS Data Should Drive PV Resource Planning
PV staffing built on intuition fails at inspection. FAERS-driven drug-risk tiering makes resource plans defensible.
Read Pharma TechnologyICH E2C(R2) and GVP Module VI: What Literature Monitoring Really Requires
Compliant literature monitoring is about reproducibility and audit trails, not just running a search.
Read